Press Release Archive
Press Releases
December 2022
12.01.2022
Financial Finance Medicines Research Vaccines Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
September 2022
09.22.2022
Prescription Medicines Medicines Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
09.09.2022
Prescription Medicines Medicines FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
August 2022
08.05.2022
June 2022
06.30.2022
Prescription Medicines Medicines Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™
06.14.2022
Prescription Medicines Medicines Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA
06.04.2022
06.02.2022
May 2022
05.06.2022
05.04.2022
April 2022
04.29.2022
04.27.2022
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.